Abstract

The effect of short-term treatment of anabolic steroid on the patients with compensated liver cirrhosis was assessed by the study on the hepatic protein synthesis in vitro. The results indicated that the treatment decreased the specific activity of hepatic trichloroacetic acid soluble fraction and increased that of hepatic trichloroacetic acid ethanol soluble fraction. Clinical studies resulted in an improvement of serum protein pattern and BSP retention, but no effect on hepatic histology. The effect of anabolic steroid on chronic liver disease was analytically discussed.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.